$STTK
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Healthcare
Sector
Biotechnology
Industry
Taylor H. Schreiber
CEO
44
Employees
$6.11
Current Price
$227.54M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 2 | $212,544.32 | 32,032 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 2 | $212,544.32 | 32,032 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 2 | $212,544.32 | 32,032 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 12, 2026 | Shukla Abhinav A. Chief Technical Officer | Sale | 2,032 | $7.01 | $14,244.32 | View Details |
| May 12, 2026 | Pandite Arundathy N. Chief Medical Officer | Sale | 30,000 | $6.61 | $198,300.00 | View Details |
4 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No past earnings data available
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies:
$TRAW โ Traws Pharma, Inc.via ORBIMED ADVISORS LLC$PRLD โ Prelude Therapeutics Incvia ORBIMED ADVISORS LLC$EWTX โ Edgewise Therapeutics, Inc.via ORBIMED ADVISORS LLC$ACET โ Adicet Bio, Inc.via ORBIMED ADVISORS LLC$MBX โ MBX Biosciences, Inc.via ORBIMED ADVISORS LLC$SION โ Sionna Therapeutics, Inc.via ORBIMED ADVISORS LLC